微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 22.86% | -10.36% | -3.98% | 120/141 | 52.4% | 佰仁医疗 | 88.71% | 行业排名> |
| 2026-03-31 | 23.81% | -13.08% | -7.36% | 118/141 | 52.37% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-12-31 | 25.7% | -5.22% | 1.53% | 115/141 | 51.9% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-09-30 | 25.31% | -6.88% | -0.74% | 114/141 | 52.23% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 25.5% | -7.86% | -6.9% | 116/141 | 52.48% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 27.39% | 0.1% | 1.01% | 111/141 | 52.13% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 27.12% | -16.38% | -0.24% | 114/141 | 53.08% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 27.18% | -17.23% | -1.78% | 111/141 | 53.87% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 27.68% | -19.83% | 1.14% | 114/141 | 53.95% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 27.36% | -28.66% | -15.62% | 111/141 | 53.88% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 32.43% | 7.44% | -1.25% | 110/141 | 53.57% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 32.84% | 12.49% | -4.87% | 103/141 | 54.44% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 34.52% | 14.55% | -10% | 104/141 | 53.81% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 38.36% | 18.11% | 27.08% | 95/141 | 54.06% | 万泰生物 | 91.61% | 行业排名> |
| 2022-12-31 | 30.18% | -7.6% | 3.39% | 113/141 | 54.01% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 29.19% | -15.1% | -3.12% | 106/141 | 55.7% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 30.14% | -16.03% | -7.21% | 110/141 | 55.37% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 32.48% | -6.54% | -0.58% | 98/141 | 56.89% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 32.67% | -30.08% | -5.01% | 114/141 | 57.98% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 34.39% | -35.15% | -4.19% | 97/141 | 59.77% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 35.89% | -34.8% | 3.28% | 102/141 | 59.05% | 正海生物 | 90.78% | 行业排名> |
| 2021-03-31 | 34.75% | -21.01% | -25.63% | 87/141 | 61.5% | 正海生物 | 91.59% | 行业排名> |
| 2020-12-31 | 46.72% | 17.48% | -11.89% | 97/141 | 60.12% | 正海生物 | 92.23% | 行业排名> |
| 2020-09-30 | 53.03% | 37.15% | -3.66% | 64/141 | 62.21% | 正海生物 | 92.69% | 行业排名> |
| 2020-06-30 | 55.04% | 46.68% | 25.11% | 72/141 | 60.36% | 正海生物 | 92.61% | 行业排名> |
| 2020-03-31 | 43.99% | 19.7% | 10.62% | 56/141 | 58.8% | 正海生物 | 94.38% | 行业排名> |
| 2019-12-31 | 39.77% | 6.84% | 2.86% | 93/141 | 56.96% | 正海生物 | 93.12% | 行业排名> |
| 2019-09-30 | 38.66% | 4.86% | 3.03% | 50/141 | 55.83% | 正海生物 | 93.78% | 行业排名> |
| 2019-06-30 | 37.53% | 0.12% | 2.1% | 60/141 | 57.93% | 正海生物 | 93.09% | 行业排名> |
| 2019-03-31 | 36.75% | -1.59% | -1.26% | 43/141 | 52.61% | 正海生物 | 93.85% | 行业排名> |
| 2018-12-31 | 37.22% | -0.28% | 0.95% | 86/141 | 56.22% | 正海生物 | 93.08% | 行业排名> |
| 2018-09-30 | 36.87% | -3.05% | -1.62% | 38/141 | 52.76% | 正海生物 | 92.83% | 行业排名> |
| 2018-06-30 | 37.48% | -2.3% | 0.36% | 43/141 | 53.06% | 正海生物 | 92.44% | 行业排名> |
| 2018-03-31 | 37.35% | -2.22% | 0.05% | 38/141 | 52.55% | 正海生物 | 92.7% | 行业排名> |
| 2017-12-31 | 37.33% | -7.81% | -1.86% | 81/141 | 56.1% | 正海生物 | 93.67% | 行业排名> |
| 2017-09-30 | 38.04% | -5.13% | -0.85% | 34/141 | 53.53% | 正海生物 | 94.14% | 行业排名> |
| 2017-06-30 | 38.36% | -0.53% | 0.44% | 44/141 | 54.85% | 正海生物 | 93.83% | 行业排名> |
| 2017-03-31 | 38.2% | 0.68% | -5.67% | 33/141 | 54.29% | 正海生物 | 93.69% | 行业排名> |
| 2016-12-31 | 40.49% | 3% | 0.99% | 59/141 | 57.35% | 正海生物 | 92.79% | 行业排名> |
| 2016-09-30 | 40.09% | -1.2% | 3.96% | 28/141 | 51.85% | 健帆生物 | 84.23% | 行业排名> |
| 2016-06-30 | 38.57% | -2.68% | 1.66% | 37/141 | 52.6% | *ST明德 | 86.71% | 行业排名> |
| 2016-03-31 | 37.94% | -4.64% | -3.5% | 25/141 | 50.24% | 健帆生物 | 83.86% | 行业排名> |